Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Staar Surgical in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Staar Surgical’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000718937-26-000023
| Line item | Three Months Ended / April 3, 2026 | Three Months Ended / March 28, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net income (loss) | $5,206 | $(54,211) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Depreciation of property, plant, and equipment | 2,107 | 2,337 |
| Amortization of cloud-based software | 104 | 53 |
| Non-cash operating lease expense | 857 | 1,028 |
| Impairment of fixed assets and operating lease right-of-use assets | — | 13,216 |
| Accretion/Amortization of investments available for sale | (232) | (129) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Staar Surgical's D&A?
- Staar Surgical (STAA) reported D&A of $2.11M in Q1 2026.
- How has Staar Surgical's D&A changed year-over-year?
- Staar Surgical's D&A decreased by 9.8% year-over-year, from $2.34M to $2.11M.
- What is the long-term trend for Staar Surgical's D&A?
- Over 4 years (2021 to 2025), Staar Surgical's D&A has grown at a 23.2% compound annual growth rate (CAGR), from $3.61M to $8.32M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Staar Surgical's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude